Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Leo Y. Luo
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Related publications
New in High Grade Serous Ovarian Cancer Treatment
Effective Pharmacotherapy
Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms With the Mitogen-Activated Protein Kinase Signaling Cascade
Molecular and Cellular Biology
Cell Biology
Molecular Biology
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
BRD4 Amplification Facilitates an Oncogenic Gene Expression Program in High-Grade Serous Ovarian Cancer and Confers Sensitivity to BET Inhibitors
PLoS ONE
Multidisciplinary
Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma
Journal of Oncology
Oncology
Low-Stage High-Grade Serous Ovarian Carcinomas
International Journal of Gynecological Pathology
Gynecology
Forensic Medicine
Pathology
Obstetrics
VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
Frontiers in Genetics
Genetics
Molecular Medicine